STgen Bio

STgen Bio

생명공학 연구

Incheon Yeonsu-gu 팔로워 467명

소개

STgen Bio (formerly DM Bio) is a CDMO specializing in the development and manufacturing of mammalian cell culture based therapeutic proteins and monoclonal antibodies. STgen Bio started as a joint venture between Dong-A Socio Holdings and Meiji Seika Pharma, which both have long histories in the pharmaceutical industry of Korea and Japan, respectively. Since its first manufacture in 2015, STgen Bio dedicates itself to matching specific demands of global biotechnology companies with highly qualified experts and state-of-the-art manufacturing facilities.

업계
생명공학 연구
회사 규모
직원 201-500명
본사
Incheon Yeonsu-gu
유형
비상장기업
설립
2015

위치

  • 기본

    45, Jisikgiban-ro

    KR Incheon Yeonsu-gu 21990

    길 보기

STgen Bio 직원

업데이트

비슷한 페이지